Mesenchymal Stem Cell Therapy for Cardiac Inflammation: Immunomodulatory Properties and the Influence of Toll-Like Receptors
Open Access
- 10 December 2013
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2013, 1-13
- https://doi.org/10.1155/2013/181020
Abstract
Background. After myocardial infarction (MI), the inflammatory response is indispensable for initiating reparatory processes. However, the intensity and duration of the inflammation cause additional damage to the already injured myocardium. Treatment with mesenchymal stem cells (MSC) upon MI positively affects cardiac function. This happens likely via a paracrine mechanism. As MSC are potent modulators of the immune system, this could influence this postinfarct immune response. Since MSC express toll-like receptors (TLR), danger signal (DAMP) produced after MI could influence their immunomodulatory properties.Scope of Review. Not much is known about the direct immunomodulatory efficiency of MSC when injected in a strong inflammatory environment. This review focuses first on the interactions between MSC and the immune system. Subsequently, an overview is provided of the effects of DAMP-associated TLR activation on MSC and their immunomodulative properties after myocardial infarction.Major Conclusions. MSC can strongly influence most cell types of the immune system. TLR signaling can increase and decrease this immunomodulatory potential, depending on the available ligands. Although reports are inconsistent, TLR3 activation may boost immunomodulation by MSC, while TLR4 activation suppresses it.General Significance. Elucidating the effects of TLR activation on MSC could identify new preconditioning strategies which might improve their immunomodulative properties.Keywords
Funding Information
- Dutch Heart Foundation
This publication has 129 references indexed in Scilit:
- Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repairProceedings of the National Academy of Sciences of the United States of America, 2011
- Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardiumThe International Journal of Cardiovascular Imaging, 2010
- Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow ConditionsPublished by Elsevier BV ,2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Macrophage roles following myocardial infarctionInternational Journal of Cardiology, 2008
- Post-infarct remodelling: contribution of wound healing and inflammationCardiovascular Research, 2008
- The immune system and cardiac repairPharmacological Research, 2008
- The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functionsThe Journal of Experimental Medicine, 2007
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006